V. Barrios et al., SERUM GASTRIN LEVEL AND GASTRIC SOMATOSTATIN CONTENT AND BINDING IN LONG-TERM PYLOROMYOTOMIZED CHILDREN, Life sciences, 55(4), 1994, pp. 317-325
Citations number
38
Categorie Soggetti
Biology,"Medicine, Research & Experimental","Pharmacology & Pharmacy
Since somatostatin inhibits basal and stimulated gastric acid secretio
n and gastrin release, it is conceivable that decreased gastric somato
statin concentration may be one of the factors responsible for gastric
hypersecretion found in patients who have undergone long-term pylorot
omy for hypertrophic pyloric stenosis. To investigate this proposal th
e somatostatin-like immunoreactivity concentration was determined in a
ntral and fundic mucosa samples from control and long-term pyloromyoto
mized children. Tn addition, somatostatin binding to cytosol from gast
ric (fundus and antrum) mucosa and fasting serum gastrin levels and se
rum gastrin response to a standard breakfast were also studied. The me
an fundic and antral somatostatin-like immunoreactivity concentrations
were significantly lower in long-term pyloromyotomized children than
in control children. The depletion of fundic and antral somatosatin-li
ke immunoreactivity content was associated with an increase in the num
ber of gastric somatostatin binding sites. The fasting serum gastrin l
evels and serum gastrin response to a standard breakfast (after 60 min
) in long-term pyloromyotomized children was significantly higher than
those in control children. Since, together with the increase of somat
ostatin binding to gastric mucosa, there is an increase in the gastrin
serum levels, despite the inhibitory effect of somatostatin on gastri
n release, the binding capacity cannot be the main factor determining
the response to somatostatin in long-term pyloromyotomized children. T
he present results suggest that both somatostatin and gastrin have som
e pathophysiologic importance in long-term pyloromyotomized children.